Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

287.78
Delayed Data
As of Jul 22
 +5.33 / +1.89%
Today’s Change
223.02
Today|||52-Week Range
401.11
-6.06%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Operating ActivitiesNet Income / Starting Line1.0B828.7M969.2M--
 
 
 
 
Depreciation151.6M156.3M149.7M--
 
 
 
 
Total Other Cash Flow75.2M80.5M25.1M--
 
 
 
 
Funds From Operations1.2B1.1B1.2B--
 
 
 
 
Funds From/For Other Operating Expenses255.7M65.3M189.5M--
 
 
 
 
Net Cash Flow - Operating Activities895.4M1.0B963.4M--
 
 
 
 
 
InvestingIncrease In Investments-2.8B-2.0B-1.9B--
 
 
 
 
Decrease In Investments2.4B699.6M1.2B--
 
 
 
 
Capital Expenditures-229.2M-186.1M-126.9M--
 
 
 
 
Net Assets From Acquisitions 0.00-2.0K0.00--
 
 
Other Investing - Uses-323.5M-326.3M-343.0M--
 
 
 
 
Net Cash Flow Investing-989.9M-1.8B-1.2B--
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings---436.0K----
 
 
Long Term Debt Reduction---17.0K----
 
 
Net Proceeds Stock Sale10.8M8.7M14.5M--
 
 
 
 
Common Preferred Redeemed-3.0B-2.0B0.00--
 
 
 
Common Dividends----------
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing-13.9M7.4M32.9M--
 
 
 
 
Other Uses - Financing62.1M12.3M0.00--
 
 
 
Net Cash Flow - Financing2.9B-2.0B47.4M--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-6.2M-15.4M15.1M--
 
 
 
 
 
Net Change In Cash2.8B-2.8B-192.4M0.00